Cargando…
Insights into COVID-19: Perspectives on Drug Remedies and Host Cell Responses
In light of the COVID-19 global pandemic caused by SARS-CoV-2, ongoing research has centered on minimizing viral spread either by stopping viral entry or inhibiting viral replication. Repurposing antiviral drugs, typically nucleoside analogs, has proven successful at inhibiting virus replication. Th...
Autores principales: | Awad, Ahmed M., Hansen, Kamryn, Del Rio, Diana, Flores, Derek, Barghash, Reham F., Kakkola, Laura, Julkunen, Ilkka, Awad, Kareem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604481/ https://www.ncbi.nlm.nih.gov/pubmed/37892134 http://dx.doi.org/10.3390/biom13101452 |
Ejemplares similares
-
SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells
por: Jiang, Miao, et al.
Publicado: (2021) -
Serological Array-in-Well Multiplex Assay Reveals a High Rate of Respiratory Virus Infections and Reinfections in Young Children
por: Kazakova, Anna, et al.
Publicado: (2019) -
Zika Virus Non-Structural Protein NS5 Inhibits the RIG-I Pathway and Interferon Lambda 1 Promoter Activation by Targeting IKK Epsilon
por: Lundberg, Rickard, et al.
Publicado: (2019) -
Insights on the Host Stress, Fear and Growth Responses to the Deoxynivalenol Feed Contaminant in Broiler Chickens
por: Ghareeb, Khaled, et al.
Publicado: (2014) -
Filovirus VP24 Proteins Differentially Regulate RIG-I and MDA5-Dependent Type I and III Interferon Promoter Activation
por: He, Felix B., et al.
Publicado: (2022)